Highlights from the American Society of Haematology 2019
The 61st American Society of Hematology Annual Meeting (ASH) took place on 7-10 December in Orlando, Florida. It was attended by over 30,000 scientists and clinicians from around the world and covered around 6,000 topics with over 700 myeloma abstracts. Here are some of our highlights from this year’s meeting. Myeloma XI There were five…
Details
Myeloma Grand Rounds
In collaboration with colleagues from the UKMF, Myeloma UK have developed a set of slides and a corresponding poster that are available to download and use in a Grand Round event.
DetailsGP education events
We have co-partnered education events for GPs with a number of Clinical Commissioning Groups across the UK.
Please get in touch if you can direct us to the relevant person in your local CCG or if you would be interested in hosting a GP education event at your hospital. Email earlydiagnosis@myeloma.org.uk
Details
GP Ten Top Tips
We have collaborated with Macmillan to produce a Myeloma 10 top tips factsheet to support myeloma diagnosis by raising GP awareness. This includes guidance on when to suspect myeloma and which blood tests should be requested. The factsheet has been reviewed by expert haematologists and Macmillan GP Advisors to ensure the content is accurate from the perspective of both primary and secondary care clinicians.
Details
NHS improvement programme aims to define ways to improve pathology services
Pathologists and pathology labs play a critical role in diagnosis and the ongoing monitoring of myeloma patients. Like many areas of the NHS, they have been under increasing pressure to provide a consistent, high standard service over the years. To help alleviate some of the pressure in pathology services and provide good practice recommendations that…
DetailsAcute kidney injury: prevention, detection and management
This NICE guideline provides recommendations for non-specialists for the identification and referral guidance for children and adults who present with symptoms or risk factors of acute kidney injury.
Myeloma UK funded research presented at ASH 2019
The 61st American Society of Hematology Annual Meeting (ASH) took place on 7-10 December in Orlando, Florida. Our Director of Research Sarah McDonald and Director of Healthcare Advocacy Services Ira Laketic-Ljubojevic attended to learn about the latest myeloma research and see the progress from Myeloma UK funded research. Results from research part-funded by Myeloma UK, the…
Details
Update on NICE review of drug approval methods
The way evidence is used to approve new treatments for use on the NHS is set to change, under a review being carried out by the National Institute for Health and Care Excellence (NICE). The review of methods, running throughout 2020, is an opportunity to address some of the challenges in approving treatments: for example, ensuring…
Details